EXMceuticals Receives Approval To Begin Trading on the Frankfurt Stock Exchange

NEWS RELEASE EXMceuticals Receives Approval To Begin Trading on the Frankfurt Stock Exchange

April 30, 2019, Vancouver, British Columbia – EXMceuticals Inc. (CSE: EXM) (FSE: EXM) (the “Company”) is pleased to announce that the Frankfurt Stock Exchange (“FSE”) has approved the listing of the Company’s common shares for trading under the securities identification code “WKN: A2PAW2” and “ISIN: CA30207T1049”. The Company’s common shares continue to be listed on the Canadian Stock Exchange under the ticker symbol “EXM”. ON BEHALF OF THE BOARD OF DIRECTORS OF EXMCEUTICALS INC.

Michel Passebon, Chief Executive Officer and Director

For further information contact: EXM Investors Relations

Telephone: +1 345-232-1569

Email: investors@exmceuticals.com

Neither the CSE, nor the FSE has approved nor disapproved the contents of this press release. Neither the CSE, nor the FSE accepts responsibility for the adequacy or accuracy of this release. Read More